Cargando…

Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial

BACKGROUND: Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease and a leading cause of death worldwide. The clinical utility of commonly used lipid-lowering drugs such as statins and fibrates is sometimes limited by the occurrence of various adverse reactions. Recently, be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Ying, Yang, Yuan-Yuan, Yang, Bao-Lin, Du, Ya-Wei, Ren, Da-Wei, Zhou, Hong-Mei, Wang, Jing, Yang, Hui-Min, Wang, Yao-Xian, Zhang, Ying-Ying, Wu, Sheng-Xian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825207/ https://www.ncbi.nlm.nih.gov/pubmed/33482853 http://dx.doi.org/10.1186/s13063-021-05028-8

Ejemplares similares

The efficacy and safety of Longmu Tang granule for the treatment of atopic dermatitis: study protocol for a single-centred, double-blinded, randomised, placebo-controlled trial
por: Li, Ya-qin, et al.
Publicado: (2022)

Statin treatment for unruptured intracranial aneurysms study: a study protocol for a double-blind, placebo-controlled trial
por: Li, Wenqiang, et al.
Publicado: (2020)

Evaluation of efficacy and safety of Qiangzhu-qinggan formula as an adjunctive therapy in adult patients with severe influenza: study protocol for a randomized parallel placebo-controlled double-blind multicenter trial
por: Qiu, Lei, et al.
Publicado: (2021)

Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Dai, Liang, et al.
Publicado: (2016)

Efficacy and safety of Tibetan medicine Qingpeng ointment for acute gouty arthritis: protocol for a multi-center, randomized, double-blind, placebo-controlled trial
por: Shang, Ya-xi, et al.
Publicado: (2022)

Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF)
por: Hou, Ya Zhu, et al.
Publicado: (2013)

Efficiency and Safety of Baofei Granules in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial
por: Sun, Yuan, et al.
Publicado: (2022)

Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial
por: Wang, Yeming, et al.
Publicado: (2020)

Study protocol: a multi-center, double-blind, randomized, 6-month, placebo-controlled trial to investigate the effect of supplementing hormone therapy FET cycles with Gushen’antai pills on the outcomes of in vitro fertilization
por: Ma, Ying-jie, et al.
Publicado: (2021)

Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial
por: Kong, Qing, et al.
Publicado: (2020)

Effectiveness and safety of Bushen Huoxue granules in treatment of premature ovarian insufficiency: study protocol for a randomized, double-blinded, placebo-controlled, and multicenter clinical trial
por: Cao, Ying, et al.
Publicado: (2021)

Efficacy and safety of Jin-shui Huan-xian granule for idiopathic pulmonary fibrosis: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Yang, Shu-guang, et al.
Publicado: (2022)

Huatan Dingji Decoction intervening in atrial fibrillation: protocol for a randomized double-blind single-simulated placebo-controlled clinical trial
por: Xiao, Ying, et al.
Publicado: (2021)

Efficacy and safety of HIMABERB® Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial
por: Panigrahi, Antarmayee, et al.
Publicado: (2023)

Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial
por: Huang, Qian, et al.
Publicado: (2023)

Efficacy and safety of Hou Gu Mi Xi in patients with spleen qi deficiency syndrome who underwent radical gastrectomy for gastric cancer: protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Zhou, Xu, et al.
Publicado: (2019)

Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials
por: Jiang, Wen-Long, et al.
Publicado: (2020)

A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease
por: Wang, Yiru, et al.
Publicado: (2019)

Efficacy and safety of Qushi Huayu granule for hyperlipidemia: study protocol for a randomized, double-blind, placebo-controlled trial
por: Sun, Yuanlong, et al.
Publicado: (2022)

The Effect of Nattokinase-Monascus Supplements on Dyslipidemia: A Four-Month Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Liu, Xiaoming, et al.
Publicado: (2023)

Chinese herbs in treatment of influenza: A randomized, double-blind, placebo-controlled trial
por: Wang, Lei, et al.
Publicado: (2010)

Study protocol for a parallel-group, double-blinded, randomized, controlled, noninferiority trial: the effect and safety of hybrid electroconvulsive therapy (Hybrid-ECT) compared with routine electroconvulsive therapy in patients with depression
por: Rong, Han, et al.
Publicado: (2019)

The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial
por: Sha, Zhongwei, et al.
Publicado: (2020)

The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2021)

Comparison of the efficacy and safety of leflunomide versus placebo combined with basic prednisone therapy in patients with active disease phase of Takayasu arteritis: study protocol for a randomized, double-blinded controlled trial (Takayasu arteritis clinical trial in China: TACTIC)
por: Sun, Ying, et al.
Publicado: (2023)

Dexmedetomidine vs. lidocaine for postoperative analgesia in pediatric patients undergoing craniotomy: a protocol for a prospective, randomized, double-blinded, placebo-controlled trial
por: Zhang, Yuan, et al.
Publicado: (2021)

Evaluation of the safety and efficacy of a Fuling-Zexie decoction for people with asymptomatic hyperuricemia: protocol for a prospective, double-blinded, randomized, placebo-controlled clinical trial
por: Yan, Jingyao, et al.
Publicado: (2022)

Effectiveness and safety of Daixie Decoction granules combined with metformin for the treatment of T2DM patients with obesity: study protocol for a randomized, double-blinded, placebo-controlled, multicentre clinical trial
por: Liu, Zhidong, et al.
Publicado: (2023)

Jiao-tai-wan for insomnia symptoms caused by the disharmony of the heart and kidney: a study protocol for a randomized, double-blind, placebo-controlled trial
por: Zeng, Congcong, et al.
Publicado: (2020)

Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya
por: Smit, Menno R, et al.
Publicado: (2016)

High prevalence of dyslipidemia and associated risk factors among rural Chinese adults
por: Sun, Guo-Zhe, et al.
Publicado: (2014)

Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study
por: Zheng, Ying, et al.
Publicado: (2017)

Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial
por: Wu, Qing-Juan, et al.
Publicado: (2020)

A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia
por: Upadya, Haridas, et al.
Publicado: (2019)

Low-dose belimumab for patients with systemic lupus erythematosus at low disease activity: protocol for a multicentre, randomised, double-blind, placebo-controlled clinical trial
por: Sun, Fangfang, et al.
Publicado: (2022)

Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial
por: Shimizu, Shinobu, et al.
Publicado: (2020)

A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset™ or placebo
por: Scranton, Richard E, et al.
Publicado: (2007)

Postoperative analgesia of scalp nerve block with ropivacaine in pediatric craniotomy patients: a protocol for a prospective, randomized, placebo-controlled, double-blinded trial
por: Xiong, Wei, et al.
Publicado: (2020)

Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study
por: Spigoni, Valentina, et al.
Publicado: (2017)

Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
por: Chen, Qi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lr535b78fa0jukctjuc71nlpih